Drug intelligence / Profile preview

Shebone XT

Development stage
Unknown
Lead developer
Neurogenics Therapeutics
Modality
Small Molecules
Administration
Oral
01

Overview

Shebone XT is a multi-ingredient therapeutic supplement developed by Neurogenics Therapeutics, primarily indicated for the management of bone-related disorders and associated nutritional deficiencies. The formulation typically combines **calcium carbonate** and **calcitriol** (the active form of Vitamin D3) to enhance intestinal calcium absorption and promote bone mineralization, making it effective for conditions such as osteoporosis and osteomalacia. Additionally, it incorporates a complex of B-vitamins, including **methylcobalamin** (Vitamin B12), **folic acid**, and **pyridoxine** (Vitamin B6). These vitamins work synergistically to lower homocysteine levels and support neuronal health, providing a comprehensive approach to managing both bone density loss and peripheral neuropathy.

Brand names
Shebone XTShebone XT-Neurogenics
02

Targets

MTR (Methionine synthase)PDXK (Pyridoxal kinase)VDR (Vitamin D receptor)DHFR (Dihydrofolate reductase)

Beyond the preview

Go deeper on Shebone XT.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shebone XT.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call